MatthewJamesMemoliMD

Infectious Disease • Bethesda, MD

Microbiology

Director, LID Clinical Studies Unit, NIAID, National Institutes of Health

Join to view full profile

Dr. Memoli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Memoli's full profile

Already have an account?

Office
Rockville Pike
Bethesda, MD 20892
Phone+1 301-443-5971

Education & Training

St. George's University School of MedicineClass of 2002
Thomas Jefferson UniversityMS, Microbiology, 1996 - 1998
National Institutes of Health Clinical CenterFellowship, Infectious Disease

Certifications & Licensure

VA State Medical License 2022 - 2026
DC State Medical License 2011 - 2022

Clinical Trials

Influenza in People With Normal and Weakened Immune Systems Start of enrollment: 2008 Jan 03
Completed
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols Start of enrollment: 2011 Jul 20
RECRUITING
Influenza A 2009 H1N1 Challenge Study in Healthy Adults Start of enrollment: 2012 Feb 01
Completed
Phase 1, Phase 2
Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People Start of enrollment: 2013 Sep 01
Completed
Phase 1, Phase 2
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs Start of enrollment: 2014 Apr 25
Completed
Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine Start of enrollment: 2017 Feb 15
Completed
Phase 1
Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine Start of enrollment: 2019 Jul 08
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

3 citations
Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease.
Saborni Chakraborty, Bowie Yik-Ling Cheng, Desmond L Edwards, Joseph C Gonzalez, David Kung-Chun Chiu
Immunity. 2025-01-14
A comparative analysis of COVID-19 seroprevalence rates, observed infection rates, and infection-related mortality.
Eric W Ford, Kunal N Patel, Holly Ann Baus, Shannon Valenti, Jennifer A Croker
Frontiers in Public Health. 2025-01-01
7 citations
Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.
Rachel Bean, Luca T Giurgea, Alison Han, Lindsay Czajkowski, Adriana Cervantes-Medina
Mbio. 2024-02-14

Press Mentions

Legislators Demand Stop to NIH Cuts They Say Will ‘Devastate’ Medical ResearchFebruary 12th, 2025
UT Austin Professor Says Trump's Policies Could Disrupt Scientific Research and Hurt the EconomyJanuary 30th, 2025
The Truth About ‘Man Flu’September 12th, 2024
Join now to see all

Other Languages

Spanish